Recent advances in genome wide sequencing techniques and analytical methods allow for more comprehensive examinations of the genome than microarray-based genome-wide association studies (GWAS). The present report provides the first application of whole genome sequencing (WGS) to identify low frequency variants involved in cannabis dependence across two independent cohorts. The present study used low-coverage whole genome sequence data to conduct set-based association and enrichment analyses of low frequency variation in protein-coding regions as well as regulatory regions in relation to cannabis dependence. Two cohorts were studied: a population-based Native American tribal community consisting of 697 participants nested within large multi-generational pedigrees and a family-based sample of 1832 predominantly European ancestry participants largely nested within nuclear families. Participants in both samples were assessed for Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) lifetime cannabis dependence, with 168 and 241 participants receiving a positive diagnosis in each sample, respectively. Sequence kernel association tests identified one protein-coding region, C1orf110 and one regulatory region in the MEF2B gene that achieved significance in a meta-analysis of both samples. A regulatory region within the PCCB gene, a gene previously associated with schizophrenia, exhibited a suggestive association. Finally, a significant enrichment of regions within or near genes with multiple splice variants or involved in cell adhesion or potassium channel activity were associated with cannabis dependence. This initial study demonstrates the potential utility of low pass whole genome sequencing for identifying genetic variants involved in the etiology of cannabis use disorders.
INTRODUCTION
Cannabis is the most widely used illicit drug in the United States, with lifetime rates of cannabis use disorders ranging from 1.5% to 2.9% (Hasin et al. 2015) . Cannabis use is associated with substantial physical and psychiatric sequelae in some users (Volkow et al. 2014 (Volkow et al. , 2016 . Given that cannabis use is expected to increase in the United States with increased decriminalization and legalization, it is of great interest to identify etiological factors that may lead to dependence. Twin studies have shown a substantial genetic component to the etiology of cannabis use disorders, with a recent meta-analysis suggesting heritability estimates of 0.51 for males and 0.59 for females (Verweij et al. 2010 ). Nonetheless, molecular genetic studies attempting to identify the specific variants involved in this genetic risk have yielded primarily mixed results.
Candidate gene studies of the endocannabinoid receptor type 1 gene (CNR1) and/or the fatty acid amide hydrolase gene (FAAH), which is involved in endocannabinoid metabolism, have reported associations with cannabis use and dependence (e.g. Tyndale et al. 2007) , marijuana withdrawal and craving (Haughey et al. 2008) and related phenotypes such as trait impulsivity (Ehlers et al. 2007 ). These results, however, have failed to achieve the current standards for genome-wide significance. Genome-wide association studies (GWAS) have identified novel loci related to cannabis use disorders, including ankyrin-repeat and fibronectin type III domain containing 1 gene, ANKFN1 (Agrawal et al.
2011
) and a gene cluster located on chromosome 17q24 [c17orf58, BPTF, PPM1D (Agrawal et al. 2014) ]. Nonetheless, these results also failed to achieve genome-wide significance. More recently, the first genome-wide significant associations were reported with loci located in or near three genes, RP11-206 M11.7, SLC35G1, CSMD1 .
The application of next generation sequencing methods to the study of complex traits presents several potential advantages over GWAS microarrays that may allow for further progress to be made. First, GWAS microarrays have been primarily designed to measure common genetic variants (i.e. minor allele frequencies [MAF] > 0.05), and thus, are not well-positioned to capture genetic variants with lower allele frequencies (Nelson et al. 2013) . As a result, rare variation has been cited by some as a potential source of the 'missing' heritability, which refers to the gap between heritability estimates of complex traits derived from twin studies and the proportion of variation in a trait explained by measured genetic variants in a GWAS, as well as the 'still missing' heritability, which refers to the gap between heritability estimates of complex traits derived from twin studies and those derived from GWAS using genomic similarity approaches (Wray & Maier 2014) , including traits such as cannabis initiation (Stringer et al. 2016) . In contrast, sequencing technologies, which directly interrogate each variant, do not have this limitation. Second, common genetic variation captured by GWAS microarrays varies as a function of the ancestral group under study thus complicating the study of diverse ancestral groups (Cantor, Lange, & Sinsheimer 2010) . More specifically, these microarrays have typically been designed to capture common variation in individuals of specific ancestral groups (e.g. European ancestry). Thus, variants specific to populations outside of these groups (e.g. American Indians) may not be captured.
Given the described advantages, the present report utilized low-coverage whole genome sequencing (WGS) to identify low-frequency risk variants for cannabis use disorders that would typically not be captured by a GWAS microarray in two independent cohorts, a populationbased sample of Native American Indians and a familybased study of individuals of predominantly European descent initially selected for alcohol dependence. The inclusion of a Native American cohort should also be emphasized given that this cohort represents an understudied population with some of the highest rates of substance use problems in the United States (Ehlers et al. 2004 ). The present study used WGS to study the relations of low frequency variants to Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) cannabis dependence using three primary analytic approaches:
(1) set-based tests of association of low frequency variants (MAF < 0.02) located in protein-coding regions of the genome, (2) set-based tests of association of low frequency variants located in regulatory regions of the genome and (3) enrichment analysis to evaluate whether genes related to associated sets shared similarities in structure or function.
MATERIALS AND METHODS
Data were collected at The Scripps Research Institute and the Gallo Institute at the University of California at San Francisco (UCSF). Assessment procedures were approved by Institutional Review Boards at each institution. Data collection procedures by The Scripps Research Institute were also approved by a tribal group overseeing health issues for the communities where recruitment took place. Notably, human subject permissions and the wishes of the participating tribes do not allow study data to be entered into public databases. Ongoing management and analysis of data collected at the UCSF site was approved by the Institutional Review Board at the University of North Carolina at Chapel Hill. Participants at both sites were fully briefed on the nature of the study, provided written informed consent prior to enrollment, and were compensated for time spent in the study.
Participants

Native American sample
Participants were recruited from eight geographically contiguous Indian communities with a total population of~3000 individuals. Individuals of Native American heritage that were between the ages of 18 and 82 years were recruited to participate using a combination of a venue-based methods for sampling hard-to-reach populations (Muhib et al. 2001 ) and a respondent-driven procedure (Heckathorn 1997) , as reported previously (Ehlers et al. 2004) . All subjects were assessed using the SemiStructured Assessment for the Genetics of Alcoholism (SSAGA) to collect demographic information and make DSM-IV cannabis dependence diagnoses. The SemiStructured Assessment for the Genetics of Alcoholism is a reliable and valid polydiagnostic psychiatric interview that has been successfully used in Native American populations (Bucholz et al. 1994) .
Of the 775 participants in the Native American sample, 697 were successfully sequenced and included in the association analyses. Sixty-seven samples could not be sequenced because of insufficient or low quality deoxyribonucleic acid (DNA), and 11, none of whom met criteria for cannabis dependence, were excluded because of sample misidentification as assessed by comparisons of self-reported familial relations to kinship coefficients derived from genotypes using PREST (Sun, Wilder, & McPeek 2002) . Among sequenced participants, 168 were diagnosed with cannabis dependence. The average age of the sample was 31.2 AE 0.5 years and 57% were female, although cannabis dependent participants were more likely to be older and male (Table 1) . Forty-two percent of participants reported at least 50% Native American heritage based on their federal Indian blood quantum (Bizon et al. 2014) .
University of California at San Francisco family study sample
The UCSF Family Study sample was recruited nationwide for inclusion in a study of the genetics of alcoholism and other substance dependence. Responding individuals were invited to participate if they met screening criteria for a lifetime alcohol dependence diagnosis and had at least one sibling or both parents available to participate. Permission was then obtained from the proband to invite relatives to participate by mail. Probands with serious drug addictions other than cannabis (e.g. stimulants, cocaine or opiates) or a history of intravenous substance use were excluded. Also excluded were subjects reporting a current or past diagnosis involving psychotic symptoms, a life-threatening illness or an inability to speak and read English.
Participants represent a subset of the UCSF Family Alcoholism Study. From the full sample, 1886 were successfully sequenced and provided complete phenotype data. From this subset, a further 54 were excluded because of sample misidentification, 10 of whom met criteria for cannabis dependence, resulting in a sample size of 1832. Within the final sample, 241 participants met criteria for cannabis dependence. The average age of the study sample was 49.0 AE 13.1 years, 62% (n = 1134) were female and 95% reported Caucasian ethnicity (n = 1737) with the remaining individuals reporting African-American (n = 52), Native American (n = 25), 'Other' (n = 17) and Asian (n = 1) ancestry. Cannabis dependent participants were more likely to be male, younger, unmarried and have an annual income <$20 000 (Table 1) .
Sequencing
Blood derived deoxyribonucleic acid was sequenced using Illumina low-coverage WGS, and genotyped using an Affymetrix Exome1A chip to assess accuracy of genotype calls from sequence data. Pair-end sequencing was performed on HiSeq2000 sequencers (Illumina, San Diego, CA). For the Native American sample, approximately 80% of samples were sequenced at a coverage depth between 3× and 12× (range: 1×-31×) with depth of coverage evenly distributed across the genome. For the UCSF Family Study sample, approximately 86% of the samples were sequenced at a coverage depth between 2× and 6× (range: 1×-18×) with depth of coverage evenly distributed across the genome. Sequence reads were aligned using blocked multiple-sequence alignment (BMA), and realigned near indels with the Genome Analysis Toolkit (GATK). Because low-pass sequencing was used and to capitalize on the fact that participants were nested within families, variants were called using the LD-aware variant caller Thunder (Li 2011) in order to increase the accuracy of the variant calls. Variant call quality was assessed through comparison of the sequencing results to exome array genotypes for all subjects resulting in a 98% concordance rate in each sample. Because the number of rare variants identified within a single study increases with sample size due to their low frequency, this low-coverage approach allowed for the sequencing of a greater number of participants and inclusion of a larger number of rare variants. This led to a greater number of identified rare variants in the UCSF Family study relative to the Native American sample, given the former's larger size. The (Bizon et al. 2014) .
Data analysis
To assess ancestry and admixture proportions in the Native American sample, we used a supervised clustering approach that used the algorithm implemented in AD-MIXTURE (Alexander, Novembre, & Lange 2009 ) in conjunction with a reference panel containing genotype information at about 300 k strand-unambiguous SNPs. The ancestry estimates were then further refined through a noise reduction approach via bootstrapping (Libiger & Schork 2013 ) and identified as corresponding to the four major continental populations: African, East Asian, European and Native American. For the UCSF Family Study, ancestry proportions were obtained using principal components analysis (Price et al. 2006) . Regression analyses examining the relations between these ancestry proportions and the cannabis diagnosis were nonsignificant (P-values: 0.366-0.890). Participants in both samples were nested in families. Thus, the linear mixed model approach implemented in Efficient Mixed-Model Association eXpedited (EMMAX) (Kang et al. 2010 ) was used to control for population substructure and genetic relatedness in all analyses. This approach calculates a genetic similarity matrix for all pairwise combinations of study participants using measured genotype data and includes this matrix as a random effect in the mixed model to partition variance in the phenotype that can be attributed to familial relatedness and population substructure. Ancestry estimates obtained as described earlier were included as covariates to fully account for potential inflation in the test statistics along with gender, age and agesquared.
For the set-based analyses, low frequency variants (MAF < 0.02) were analyzed using the optimized sequence kernel association test (SKAT-O; Lee et al. 2012a) implemented within the EMMAX framework. Only sets for which at least 1% of participants in each sample carried a low frequency variant were included in the analysis. Specifically, if only a small proportion of the study participants carry a rare variant within a given set (i.e. < 1% of the study sample), the resulting analysis would be similar to analyzing a low frequency variant in isolation, and thus, will be particularly susceptible to chance fluctuations in the data, given that the result is based on only a handful of observations. For sets based on the coding regions of genes, all variants within the protein coding region were retained, including nonsynonymous, synonymous, start codon loss or gain and stop codon loss or gain variants. For sets based on regulatory elements, the decision was made to focus on regulatory elements that showed evidence of persisting across tissue types, given that little is known regarding the etiology of cannabis dependence and alterations in gene expression both inside and outside of the central nervous system are of potential relevance. We considered restricting this analysis to only regulatory elements influencing genes expressed in the central nervous system; however, many regions were located in close proximity to more than one gene or in intergenic regions, making it difficult to assign many of these regions to a specific gene. Because the primary effect of including non-CNS expressed genes in the analysis was the adoption of a more conservative significance threshold, the decision was made to include all regulatory regions in the analysis. Thus, data from the NIH Roadmap Epigenomics project focused on identifying epigenetic marks across tissues were accessed and used to define the boundaries of the regulatory elements (Roadmap Epigenomics Consortium et al. 2015) ; HoneyBadger2 dataset accessed on 12/15/2015 from http://www.broadinstitute.org/~meuleman/reg2map/). Because some of these elements are quite small (150 base pairs (bp)) and frequently lie close together, elements within 2 kilobases (kb) of each other were combined into a single element.
All analyses were performed separately for each cohort within the EPACTS software pipeline (Kang 2014) . A weighted Z-score approach (Stouffer et al. 1949 ) was used to combine results across samples. Enrichment analyses were conducted using the Database for Annotation, Visualization and Integrated Discovery (DAVID; Huang, Sherman, & Lempicki 2009 ) in which genes with Pvalues < 0.005 were evaluated to determine whether they were over-represented in any gene categories. These analyses were conducted using a custom background that included only those genes tested in the set based tests of coding regions and regulatory elements, respectively.
RESULTS
Analysis of protein-coding regions
We first conducted set-based analyses of the genes in the RefSeq database; 12,662 genes were identified that met the described inclusion criteria, resulting in a critical P-value of 3.9eÀ6 to determine significance. A single gene that met this criterion was identified in meta-analysis, a coiled-coil domain containing protein on chromosome 1, C1orf110 (P = 3.20eÀ6) (see Table 2 ; also see Supporting Information Table S1 for top results in each cohort, Supporting Information Figs S1 & S2 for q-q plots of the distribution of P-values in each cohort). Notably, these analyses were repeated when restricting the UCSF Family Study sample to participants that were of predominantly European ancestry (>70%; n = 1641) as indicated by the principal components analysis. The number of excluded participants was greater than the number of participants that selfreported non-European ancestry due to discordances between self-report and genetically derived ancestry estimates. The meta-analytic result for C1orf110 was similar (P = 4.66eÀ6), but no longer met the significance threshold after dropping these participants. A similar, although slightly larger, drop in the P-value was observed when the same number of randomly selected European ancestry participants were dropped from the analysis (P = 2.14eÀ5). Together, these results suggest the change in significance likely reflects a decrease in statistical power following the exclusion of almost 200 participants rather than unaccounted for population substructure. Figure 1 displays the layout of the gene and the location of the variants included in the test for each sample. To further explore the relations of these variants to cannabis dependence, the Polyphen, SIFT and Provean databases were queried to estimate the likely impact of these variants on gene function. The resulting values are shown in Table 3 alongside the single variant EMMAX results, which provide an indication of the direction and magnitude of their relation with cannabis dependence. An examination of this table suggests that, within the UCSF Family Study sample, variants predicted to negatively impact protein function show stronger relations to the cannabis dependence diagnosis. The results are less clear for the Native American sample; however, the one variant that does show a relation with cannabis dependence (rs187742957) is predicted to negatively impact the encoded protein. We then conducted an enrichment analysis based on the SKAT-O results using DAVID. This analysis suggested an over-representation of genes in several pathways related to potassium channel activity, including potassium ion transport (GO:0006813: Benjamini-Hochberg corrected P = 0.013), cation channel complex (GO:0034703: Benjamini-Hochberg corrected P = 0.036), voltage-gated potassium channel complex (GO:0008076: Benjamini-Hochberg corrected P = 0.040), potassium channel complex (GO:0034705: Benjamini-Hochberg corrected P = 0.040) and potassium channel activity (GO:0005267: Benjamini-Hochberg corrected P = 0.043).
The genes contributing to these results included KCNK17, RYR2, SLC24A3, KCNJ4 and SLC24A2.
Analysis of regulatory elements
We then conducted set-based analyses of regulatory elements identified by the NIH Roadmap Epigenomics project (Roadmap Epigenomics Consortium et al. 2015) that were consistently observed across tissue types; 165,586 elements were identified that met the inclusion criteria for this analysis resulting in a critical P-value of 3.0eÀ7 that was used to determine significance. One regulatory element met this threshold (Table 4 ; also see Supporting Information Table S2 for top results in each cohort, Supporting Information Figs S3 & S4 for q-q plots of the distribution of P-values in each cohort). Variants contained within the first intron of the myocyte enhancer factor 2B gene (MEF2B) showed a significant relation with cannabis dependence across samples (combined P-value = 1.28EÀ08).
As shown in Fig. 2 , the significant region is characterized by the presence of both H3K9me3 and H3K36me histone marks, a pattern that has been associated with the preservation of exons from recombination and regulation of alternative splicing. A query of the Ensemble database does include a MEF2B transcript (ENST00000409447) that is annotated as having an untranslated exon in this region (bottom of Fig. 2 ). This analysis was repeated when restricting the UCSF Family Study sample to those participants of predominantly European ancestry and again dropping the same number of European ancestry participants at random. The P-value for the association with the MEF2B element fell by an order of magnitude and became non-significant when non-European ancestry participants were removed from the analysis (P = 3.52eÀ7). The P-value dropped by half an order of magnitude when a random set of European ancestry participants were removed from the analysis (P = 7.80eÀ8), but continued to meet the significance threshold. Given the relative similarity in the decline of the P-value, it is likely that these changes resulted from reduced statistical power rather than unaccounted for population stratification. A suggestive association was also observed for a regulatory element within the third intron of the propionylCoA carboxylase beta subunit gene (PCCB; combined P- Table 4 Association results (P < 0.001) for set-based analysis of regulatory elements and cannabis dependence. Note: Chrom. = chromosome, D = dyadic, E = enhancer, P = promoter. UCSF = University of California at San Francisco. value = 1.55EÀ06). As shown in Fig. 3 , this regulatory element is characterized by the presence of H3K4me1 histone marks as well as the absence of H3K27ac marks, which have been suggested to reflect poised enhancers that become active during cell differentiation and reflect activity of the gene in the cell's adult state. Data from the Roadmap Epigenomics project suggest the presence of these marks in relation to this intronic regulatory region is most pronounced in brain tissues, suggesting a role for PCCB in neural development and function. This association became slightly stronger when the UCSF Family Study sample was restricted to participants of European ancestry (P = 3.51eÀ7) and weaker when dropping a random set of European ancestry participants (P = 3.04eÀ5). Enrichment analyses were then conducted using DA-VID by assigning individual regulatory elements to the nearest gene within 5000 kb. This analysis suggested an over-representation of genes that exhibit multiple splice variants (uniprot keywords: alternative splicingBenjamini-Hochberg corrected P = 4.2eÀ07; uniprot sequence annotation: splice variant-Benjamini-Hochberg corrected P = 4.6eÀ06) as well as genes related to cell adhesion (Panther BP00124-Benjamini-Hochberg corrected P = 0.010) and neurogenesis (Panther BP00199-Benjamini-Hochberg corrected P = 0.042).
DISCUSSION
The present report represents, to our knowledge, the first study to utilize next generation sequencing technology to identify low-frequency genetic variants related to cannabis dependence. Three approaches were taken to accomplish this: (1) set-based tests of association of low frequency (MAF < 0.02) coding variants, (2) set-based tests of association of low frequency variants within regulatory regions identified by the NIH Roadmap Epigenomics project and (3) enrichment analysis to evaluate whether specific gene-based or regulatory-based sets were associated with cannabis dependence. Analyses were conducted in two distinct cohorts, a Native American community sample and participants from the UCSF Family Alcoholism study, and results were combined to identify variants and genes that confer risk for cannabis dependence across samples.
The set-based analyses of low frequency variation in protein-coding regions yielded a single genome-wide significant association between cannabis dependence (Zhou et al. 2011) and the coiled-coil domain-containing protein gene (C1orf110) on chromosome 1. Adding to the strength of this finding, the pattern of results for the individual variants within the coding regions of this gene was highly concordant with predictions regarding the impact of the individual variants on C1orf110 function, at least in the UCSF study sample. Although the result was weaker in the Native American sample, the one variant that did show a relation with cannabis dependence was predicted to negatively impact the C1orf110 protein. Interpretation of this result is somewhat complicated given that little is known about the C1orf110 protein. Nonetheless, the gene does appear to be a downstream target of the NAD-dependent deacetylase sirtuin-2, which plays an important role in cellular responses to oxidative stress (Liu et al. 2013) . Notably, SIRT-2 shows altered expression in the hippocampus following repeated exposure to Δ 9 -THC (Quinn et al. 2008) , and thus, may provide an avenue of research for future studies investigating how C1orf110 may be related to cannabis dependence.
The set-based analyses of regulatory regions also yielded a single genome-wide significant association. Variation within a regulatory region located in the first intron of MEF2B was associated with risk for cannabis dependence. This element was characterized by H3K9me3 and H3K36me histone marks, suggesting the region may be important for protecting exons from recombination and regulation of alternative splicing (Schor et al. 2009 ). In contrast to variants in protein-coding regions where in silico tools (e.g. Polyphen, SIFT) can be used to make strong predictions regarding their impact on function, similar predictions regarding the impact of variants in regulatory regions on expression are not currently available, limiting the ability to determine which variants in the region might be most strongly related to cannabis dependence risk. Nonetheless, the MEF2B protein, and the MEF protein family in general, are of direct relevance to substance use phenotypes. In vitro studies have demonstrated that these proteins play important roles in synapse formation and plasticity (Flavell et al. 2006) . In the anterior cingulate and hippocampus, where MEF2B is prominently expressed, increased MEF expression leads to decreases in dendritic spine density and has been shown to result in disrupted memory formation (Rashid, Cole, & Josselyn 2014) . In the nucleus accumbens, suppression of MEF2 proteins is necessary for the observed increase in dendritic spine density that follows cocaine administration (Pulipparacharuvil et al. 2008 ). Thus, it may be that variation in MEF2B Image was generated using the WashU Epigenome Browser (Zhou et al. 2011) influences memory formation and associative learning with respect to substance use.
Although not significant, a second regulatory element yielded suggestive evidence for association with cannabis dependence risk. This element was located in an intron of the PCCB gene, which encodes for the propionyl-CoA carboxylase (PCC) enzyme beta subunit, an enzyme involved in the metabolism of several amino acids, lipids and cholesterol. Loss of function mutations in this gene lead to propionic acidemia, a condition that leads to the toxic buildup of propionyl-CoA in the nervous system and can lead to developmental delays, intellectual disability, in some cases, psychosis (Dejean de la Bâtie et al. 2014) . Of note, PCCB is also located in a region that was associated with increased risk for schizophrenia in the largest genome-wide association study of that disorder conducted to date (Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014), which is of interest given the putative link between adolescent cannabis use and increased risk for psychosis (Volkow et al. 2016) .
In comparing the set-based tests of protein-coding and regulatory regions, a higher degree of concordance was observed across study samples for the latter tests. It is likely that risk variants unique to each population exist, which could explain the discrepant results for the analysis of protein-coding regions. Nonetheless, previous reviews suggest that such differences are unlikely to account for a substantial proportion of the heritability of substance use phenotypes (Ehlers & Gizer 2013) , and would not explain the higher concordance rates for the analysis of regulatory elements. An alternative explanation, although speculative, is that the difference in consistency may be a reflection of the contributions of variation in protein-coding relative to regulatory regions to the etiology of complex phenotypes such as marijuana dependence. Previous studies have indicated that variants associated with complex traits contained in the GWAS catalog are more likely to be located within intronic and other regulatory regions of a gene rather than the protein-coding region (Nicolae et al. 2010) . As a result, it is possible that the greater consistency observed across samples for the set-based tests of regulatory elements may reflect a greater proportion of 'true' signals, relative to those in the protein-coding regions.
With respect to the significant results reported in the present study, it should be noted that the SKAT-O test analyzes the correlations among individual variant score tests within a set, and it cannot provide an estimate of explained variance attributable to the combined set of variants. Nonetheless, the effects sizes for the individual variants within sets ranged from R 2 = 0.0-0.015, suggesting effect sizes comparable to those found in GWAS. This has important implications for future studies seeking to relate low frequency variation to complex psychiatric traits such as substance use. As noted, rare variation has been cited by some as a potential source of the 'missing' heritability of complex traits (Wray & Maier 2014) . The present report suggests that low frequency variants of modest-to-large effect are unlikely to play an outsized role in the etiology of cannabis dependence at the population level, although this does not rule out the possibility that such variants may have larger effects within families. Studies of de novo variation in autism and schizophrenia suggest that moderately penetrant rare variants related to these disorders may be distributed across a broad set of genes (Neale et al. 2012) . If a similarly polygenic architecture can be assumed for substance use disorders, this suggests that large samples will be required to detect associations with low frequency variants even when setbased aggregation approaches, such as the SKAT-O test, are implemented.
This may also explain why there was little overlap observed with previous GWAS of cannabis dependence (Agrawal et al. 2011 (Agrawal et al. , 2014 Sherva et al. 2016) . Although some discrepancies should be anticipated given the focus of GWAS on common variation and the focus of the present report on low-frequency variants, the genes involved should show some degree of replication if they are associated with risk for the disorder (Visscher et al. 2012) . As sample sizes examining each type of variation increase allowing for more powerful tests of association, it would be expected that results from these studies would converge on an overlapping set of genes involved in risk for cannabis dependence.
Pathway analyses allow for the aggregation of even larger variant sets relative to set-based analyses of specific genomic elements, and thus, represent another approach for studying low frequency variation in relation to complex traits. Analyses conducted in the present study revealed the strongest relations between cannabis dependence and two gene-sets characterized by genes with multiple splice variants. This is of particular interest given that variants influencing the alternative splicing of a gene are overrepresented within the NHGRI GWAS catalog (Lee et al. 2012b) . Additionally, alternative splicing processes are critically involved in human brain development (Johnson et al. 2009 ), and there is emerging evidence that these processes may be disrupted in psychiatric disorders, including schizophrenia (Barry et al. 2014) and substance use disorders (Moyer et al. 2011) . Finally, previous GWAS have shown relations between genes included in potassium channel cocaine dependence (Gelernter et al. 2014b ) and opioid dependence (Gelernter et al. 2014a) and between substance use disorders and cell adhesion genes (e.g. Edwards et al. 2015), providing further evidence supporting the role of these gene pathways in the etiology of cannabis use disorders.
Given the promising nature of the described results, it is important to note that the modest sample size, although large for a WGS study, represents a limitation of the present study. As stated, the significant associations of the protein-coding regions of C1orf110 and the regulatory element within MEF2B became non-significant when the UCSF Family Study sample was restricted to European ancestry participants, but very similar results were observed when a random set of European ancestry individuals were dropped from the analysis. This suggests the changes in P-values resulted from the~10% reduction in sample size, and that the overall results were not inflated by the inclusion of ancestrally diverse individuals. Further, a post-hoc power analysis was conducted, indicating that the set-based tests of protein-coding regions had power = 0.56 and the tests of regulatory regions had power = 0.47 to detect a significant effect, 1 which were reduced when restricting the UCSF Family Study sample to European ancestry individuals. Together, this highlights an important difficulty in conducting WGS studies, given the associated costs, and emphasizes the need for large-scale collaborative efforts such as those that have been developed for GWAS.
In conclusion, it is important to emphasize the unique nature of the present study. To our knowledge, this is the first study to use whole genome sequence data to conduct genome-wide analyses of low frequency variation in relation to cannabis dependence. Thus, the comprehensive nature of the data analyzed presents an important advance over previous studies conducted using genotyping microarrays. This is particularly relevant to the study of Native Americans given that they represent a historically under-studied population. By using a WGS approach, the present report provides initial data suggesting that functional variation in C1orf110 and variation potentially involved in the regulation of MEF2B and PCCB expression play an important role in the etiology of cannabis dependence. Nonetheless, replication will be an important to step in evaluating the robustness of the reported results.
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